Global Cold and Flu Supplements Market to Reach $27.7 Billion by 2030
The global market for Cold and Flu Supplements estimated at US$19.5 Billion in the year 2023, is expected to reach US$27.7 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Vitamins & Minerals, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$10.8 Billion by the end of the analysis period. Growth in the Herbal Extracts segment is estimated at 5.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $5.2 Billion, While China is Forecast to Grow at 8% CAGR
The Cold and Flu Supplements market in the U.S. is estimated at US$5.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 4.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.9 Billion by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook